IMR Press / EJGO / Volume 25 / Issue 1 / pii/2004113

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

The relationship between expression of p53/bcl-2 and clinicopathological criteria in endometrioid adenocarcinomas of the endometrium

Show Less
1 Department of Pathology, Faculty of Medicine, University of Gaziantep, Turkey
2 Department of Gynecology & Obstetrics, Faculty of Medicine, University of Gaziantep, Turkey
3 Department of Pathology, Faculty of Medicine, University of Harran, Sanliurfa, Turkey
4 Department of Medical Biology & Genetics, Faculty of Medicine, University of Gaziantep, Turkey
Eur. J. Gynaecol. Oncol. 2004, 25(1), 79–80;
Published: 10 February 2004
Abstract

Objective: Thirty patients with endometrioid adenocarcinomas of the endometrium who had undergone total abdominal hys­terectomy and bilateral salpingo-oophorectomy were reviewed histopathologically. Materials and Methods: Tissues were stained immunohistochemically with p53 and bcl-2, respectively. Ten cases were selected as grade 1, ten cases grade 2 and ten cases grade 3. Results: We observed 14 cases (46.6%) of bcl-2 and four cases (13.3%) of p53 positivity; p53 expression showed an opposite cor­relation to bcl-2 staining, estrogen and progesterone. Conclusion: We observed a decrease in bcl-2 reactivity and an increase in p53 positive staining as the histological differentiation worsened.

Keywords
p53
bcl-2
Endometrioid adenocarcinomas
Endometrium
Share
Back to top